SCHEMBL30185409

CC(=O)N[C@H]1[C@H](OC[C@H]2OC(O)[C@H](NC(C)=O)[C@@H](O[C@@H]3O[C@H](CO)[C@H](O)[C@H](O[C@]4(C(=O)O)C[C@H](O)[C@@H](NC(C)=O)[C@H]([C@H](O)[C@H](O)CO)O4)[C@H]3O)[C@H]2O)O[C@H](CO)[C@@H](O[C@@H]2O[C@H](CO)[C@H](O)[C@H](O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3NC(C)=O)[C@H]2O)[C@@H]1O

nearest known ligand 0.70

Predicted protein targets (top 5)

	gene	UniProt	supporting neighbours	confidence
▸	SIGLEC7	Q9Y286	6/20	0.70

▸	MAG	P20916	8/20	0.62

▸	SELL	P14151	1/20	0.56

▸	SELP	P16109	1/20	0.56

▸	SELE	P16581	4/20	0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
SCHEMBL31701726	0.97	SIGLEC7 (0.70)	SIGLEC7MAGSELLSELPSELE
SCHEMBL31701618	0.97	SIGLEC7 (0.70)	SIGLEC7MAGSELLSELPSELE
SCHEMBL30970757	0.97	SIGLEC7 (0.70)	SIGLEC7MAGSELLSELPSELE
SCHEMBL31701577	0.97	SIGLEC7 (0.70)	SIGLEC7MAGSELLSELPSELE
SCHEMBL30185412	0.97	SIGLEC7 (0.72)	SIGLEC7MAGSELLSELPSELE
SCHEMBL31700654	0.97	SIGLEC7 (0.69)	SIGLEC7MAGSELLSELPSELE
SCHEMBL31701596	0.96	SIGLEC7 (0.72)	SIGLEC7MAGSELLSELPSELE
SCHEMBL31701512	0.96	SIGLEC7 (0.72)	SIGLEC7MAGSELLSELPSELE
SCHEMBL31700339	0.96	SIGLEC7 (0.72)	SIGLEC7MAGSELLSELPSELE
SCHEMBL31701002	0.95	SIGLEC7 (0.68)	SIGLEC7MAGSELLSELPSELE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
EP-4370664-A1	LACTO-N-BIOSE CONVERTING FUCOSYLTRANSFERASES	Inbiose N.V. (BE)	2024-05-22	—	—	EP	disclosed
WO-2023285650-A1	LACTO-N-BIOSE CONVERTING FUCOSYLTRANSFERASES	INBIOSE N.V. (BE)	2023-01-19	—	—	WO	disclosed